Abstract
ObjectivesTo evaluate long-term Brain Volume Loss (BVL) in patients who received fingolimod 0.5 mg or placebo in the FREEDOMS or FREEDOMS-2, and LONGTERMS studies. Methodspooled-analysis of patients who completed FREEDOMS...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have